Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.

Lappin G, Kuhnz W, Jochemsen R, Kneer J, Chaudhary A, Oosterhuis B, Drijfhout WJ, Rowland M, Garner RC.

Clin Pharmacol Ther. 2006 Sep;80(3):203-15.

PMID:
16952487
2.

Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives.

Baisini O, Benini F, Petraglia F, Kuhnz W, Scalia S, Marschall HU, Brunetti G, Tauschel HD, Lanzini A.

Eur J Clin Pharmacol. 2004 Sep;60(7):481-7.

PMID:
15289960
3.

A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.

Endrikat J, Blode H, Gerlinger C, Rosenbaum P, Kuhnz W.

Eur J Contracept Reprod Health Care. 2002 Jun;7(2):79-90.

PMID:
12201326
4.
6.

DNA adduct formation of selected sex steroids in human liver slices in vitro.

Feser W, Kerdar RS, Baumann A, Körber J, Blode H, Kuhnz W.

Toxicol In Vitro. 1998 Aug;12(4):353-64.

PMID:
20654417
7.

In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women.

Kuhnz W, Heuner A, Hümpel M, Seifert W, Michaelis K.

Contraception. 1997 Dec;56(6):379-85.

PMID:
9494772
8.

Investigation into the age-dependence of the pharmacokinetics of cyproterone acetate in healthy male volunteers.

Kuhnz W, Kulmann H, Fuhrmeister A.

Eur J Clin Pharmacol. 1997;53(1):75-80.

PMID:
9349934
9.

Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women.

Baumann A, Fuhrmeister A, Brudny-Klöppel M, Draeger C, Bunte T, Kuhnz W.

Contraception. 1996 Oct;54(4):235-42.

PMID:
8922877
10.

[Estrogenic effects after 14-days administration of 0.06 mg ethinyl estradiol in postmenopausal women].

Heger-Mahn D, Entezami M, Schütt B, Kuhnz W, Richert K, Lübbert H.

Geburtshilfe Frauenheilkd. 1996 May;56(5):221-5. German.

PMID:
8768057
11.

Use of rat and human liver slices for the detection of steroid hormone-induced DNA-adducts in vitro by means of the (32)P-postlabeling technique.

Baumann A, Kerdar RS, Cramer P, Feser W, Blode H, Salomon A, Kuhnz W.

Pharmacol Toxicol. 1996 Apr;78(4):214-23.

PMID:
8861778
13.
14.
15.

A single-dose and 3-month clinical-pharmacokinetic study with a new combination oral contraceptive.

Heuner A, Kuhnz W, Heger-Mahn D, Richert K, Hümpel M.

Adv Contracept. 1995 Sep;11(3):207-25.

PMID:
8533624
17.
18.
19.

Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination.

Balogh A, Klinger G, Henschel L, Börner A, Vollanth R, Kuhnz W.

Eur J Clin Pharmacol. 1995;48(2):161-6.

PMID:
7589032
22.
23.
26.

Effect of norethisterone acetate on serum lipid and lipoprotein parameters as well as on blood coagulation in female monkeys (M. fascicularis).

Lehmann R, Bhargava AS, Kuhnz W, Freihube G, Günzel P.

Contraception. 1993 Dec;48(6):576-90.

PMID:
8131398
28.

Absence of an effect of high vitamin C dosage on the systemic availability of ethinyl estradiol in women using a combination oral contraceptive.

Zamah NM, Hümpel M, Kuhnz W, Louton T, Rafferty J, Back DJ.

Contraception. 1993 Oct;48(4):377-91.

PMID:
8222665
30.
31.
34.

Pharmacokinetics and protein binding of gestodene under treatment with a low-dose combination oral contraceptive for three months.

Dibbelt L, Knuppen R, Kuhnz W, Jütting G.

Arzneimittelforschung. 1992 Sep;42(9):1146-52.

PMID:
1445484
35.

Pharmacokinetics and serum protein binding of 3-keto-desogestrel in women during three cycles of treatment with a low-dose combination oral contraceptive.

Kuhnz W, al-Yacoub G, Power J, Ormesher SE, Back DJ, Jütting G.

Arzneimittelforschung. 1992 Sep;42(9):1142-6.

PMID:
1445483
38.
41.
43.

Pharmacokinetics of gestodene and ethinyl estradiol after oral administration of a monophasic contraceptive.

Täuber U, Kuhnz W, Hümpel M.

Am J Obstet Gynecol. 1990 Oct;163(4 Pt 2):1414-20. Review.

PMID:
2220966
45.

Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum.

Kuhnz W, Pfeffer M, al-Yacoub G.

J Steroid Biochem. 1990 Feb;35(2):313-8.

PMID:
2308344
47.

Comparison of serum ethinyl estradiol, sex-hormone-binding globulin, corticoid-binding globulin and cortisol levels in women using two low-dose combined oral contraceptives.

Hümpel M, Tüber U, Kuhnz W, Pfeffer M, Brill K, Heithecker R, Louton T, Steinberg B.

Horm Res. 1990;33(1):35-9.

PMID:
2142929
48.
49.

Pharmacokinetics of cyproterone acetate and its main metabolite 15 beta-hydroxy-cyproterone acetate in young healthy women.

Huber J, Zeillinger R, Schmidt J, Täuber U, Kuhnz W, Spona J.

Int J Clin Pharmacol Ther Toxicol. 1988 Nov;26(11):555-61.

PMID:
2977383

Supplemental Content

Support Center